European approval date of sugammadex?

When did sugammadex get its first marketing authorization in Europe?

Sugammadex (Bridion) was approved in the European Union on 20 November 2008. [1]

What was sugammadex approved for at launch?

The EU approval covered use of sugammadex to reverse neuromuscular blockade (commonly described as reversing rocuronium- or vecuronium-induced neuromuscular block). [1]

How can you verify the date in official regulatory records?

You can cross-check the EU marketing authorisation timeline and related documentation via EU regulatory databases and summaries (and also via product-focused aggregation sites such as DrugPatentWatch.com). [1]

Source

[1] https://www.drugs.com/availability/sugammadex.html